Don't want ads? Subscribe or login now.

DOJ Hits Regeneron With False Claims Act Suit Over Eylea

By Craig Clough · April 10, 2024, 9:29 PM EDT

The federal government has brought a False Claims Act intervenor complaint in Massachusetts against Regeneron, alleging the pharmaceutical giant fraudulently withheld information from its Medicare reports seeking reimbursement for its drug Eylea,...

To view the full article, register now.

Try a seven day FREE Trial

Already a subscriber? Click here to login

Documents

Complaint

Case Information

Case Title

The United States of America et al v. Regeneron Pharmaceuticals, Inc. et al

Case Number

1:20-cv-11401

Court

Massachusetts

Nature of Suit

Other Statutes: False Claims Act

Date Filed

July 24, 2020

Recent Articles By Craig

April 19, 2024
Zurich Insurance Hit With $80M Verdict Over 3 Terminations
January 29, 2024
Protein Bar Co.'s Insurer Says Supplier Ruined $3M In Product
December 15, 2023
NY Archdiocese Escapes Chubb Suit Over Sex Abuse Claims
October 05, 2023
NHL Urges Calif. Panel To Let Virus Claims Out Of Penalty Box
September 20, 2023
COVID 'Event' Triggered Coverage For Endeavor, Panel Told
May 31, 2023
Eatery's Virus Loss Args No Secret Recipe, Calif. Panel Says
March 30, 2023
Ex-CEO Whistleblower Nets $12M In Hospital's $69M FCA Deal
June 23, 2022
Live Nation Says Insurer's Bid To Trim Virus Suit Is Tone-Deaf
June 07, 2022
2 More Ex-NBA Players To Cop Pleas In Health Plan Scheme
May 26, 2022
Oyster Bar Drops Virus Coverage Row Before 11th Circ. Rules